Literature DB >> 8832149

Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.

M F Gagnadoux1, R Habib, M C Gubler, J L Bacri, M Broyer.   

Abstract

The short-term prognosis of the "typical", "post-enteropathic" form of infantile HUS is usually good, with a complete recovery of renal function. However, the extent of the renal damage observed on some biopsies may raise concern for the long-term prognosis. Therefore, we studied the outcome of 29 patients affected with classical HUS in infancy or early childhood and followed-up for 15-28 years (m = 18 yrs). Initial renal symptoms ranged from a moderate renal failure with normal diuresis to a 12-day anuria: 21 children had to be treated by peritoneal dialysis. Twenty-five patients underwent a renal biopsy shortly after recovery: lesions of glomerular thrombotic microangiopathy (TMA) were found in 14 patients, and patchy cortical necrosis was diagnosed in the other 11. At latest examination 10 patients had no renal abnormality, 12 had residual renal symptoms (hypertension in 7, proteinuria in 4 and midly reduced GFR in 1), 3 were in chronic renal failure (CRF), and 4 had reached end-stage renal failure (ESRF) 16-24 years after onset; 2 of these latter 4 had a normal GFR at 10-year examination. The long-term evolution was not correlated with the initial clinical severity but appeared well correlated with the extent of the histological damage: 10 of the 11 patients with cortical necrosis have either ESRF (4), CRF (3) or renal sequelae (3), and 4 of the 5 patients with TMA involving more than 50% of glomeruli present with moderate sequelae, whereas the 9 patients with TMA involving less than 50% of glomeruli are symptom-free or have mild sequelae. Thus, the risk of renal failure 20 years after a seemingly cured childhood HUS is not negligible, and renal histology is the best indicator of long-term prognosis.

Entities:  

Mesh:

Year:  1996        PMID: 8832149

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  17 in total

Review 1.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

2.  Pediatric acute kidney injury: it's time for real progress.

Authors:  Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

3.  Bleeding risk for surgical dialysis procedures in children with hemolytic uremic syndrome.

Authors:  Brent R Weil; Sharon P Andreoli; Deborah F Billmire
Journal:  Pediatr Nephrol       Date:  2010-04-27       Impact factor: 3.714

4.  Prognostic significance of microalbuminuria in postdiarrheal hemolytic uremic syndrome.

Authors:  Randall Lou-Meda; Robert S Oakes; Jarom N Gilstrap; Christopher G Williams; Richard L Siegler
Journal:  Pediatr Nephrol       Date:  2006-09-12       Impact factor: 3.714

Review 5.  Management of acute kidney injury in children: a guide for pediatricians.

Authors:  Sharon P Andreoli
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

6.  Endothelial dysfunction during long-term follow-up in children with STEC hemolytic-uremic syndrome.

Authors:  Martin Kreuzer; Laura Sollmann; Stephan Ruben; Maren Leifheit-Nestler; Dagmar-Christiane Fischer; Lars Pape; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2017-02-08       Impact factor: 3.714

Review 7.  Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Authors:  Joann M Spinale; Rebecca L Ruebner; Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2013-01-04       Impact factor: 3.714

8.  Long-term follow-up of Argentinean patients with hemolytic uremic syndrome who had not undergone dialysis.

Authors:  Carlos J Cobeñas; Laura F Alconcher; Ana P Spizzirri; Ricardo C Rahman
Journal:  Pediatr Nephrol       Date:  2007-06-13       Impact factor: 3.714

Review 9.  The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children.

Authors:  Chantal Loirat; Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2003-09-17       Impact factor: 3.714

10.  Characterization of the cytokine immune response in children who have experienced an episode of typical hemolytic-uremic syndrome.

Authors:  Soeren Westerholt; Anne-Kathrin Pieper; Martin Griebel; Hans-Dieter Volk; Thomas Hartung; Renate Oberhoffer
Journal:  Clin Diagn Lab Immunol       Date:  2003-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.